Clinical trial
OSNA Neoadjuvant Feasibility Study in Breast Cancer Patients
NCT01140776 is registered in ClinicalTrials.gov with Sysmex America, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OSNA Neoadjuvant Feasibility Study in Breast Cancer Patients
- Lead sponsor
- Sysmex America, Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- November 30, 2010
- Completion date
- July 31, 2012
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.